Kriti Nutrients Ltd Q1 FY27 Results: Standalone & Consolidated Financials Approved
Kriti Nutrients Ltd's Board approved Q1 FY27 unaudited standalone and consolidated financial results on Aug 11, 2026. Standalone revenue was ₹24,707.76 lakhs, with a net profit of ₹905.66 lakhs. Consolidated revenue was ₹24,707.76 lakhs, with a net profit of ₹891.85 lakhs. EPS stood at ₹1.81 (standalone) and ₹1.78 (consolidated).
The announcement relates to the quarterly financial results, which are a key indicator of a company's performance and financial health. Investors and stakeholders closely monitor these results to make informed decisions.
The announcement reports the approval of financial results. While the results themselves are factual, there's no explicit positive or negative commentary from the company or auditors that would sway the sentiment. The performance metrics are presented factually.
Kriti Nutrients Limited has announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors, in their meeting held on August 11, 2026, which commenced at 3:00 PM and concluded at 4:15 PM, considered and approved these results along with the Limited Review Report from the statutory auditors.
The financial results for the quarter ended June 30, 2026, show standalone revenue from operations at ₹24,707.76 lakhs and consolidated revenue from operations at ₹24,707.76 lakhs. Standalone net profit after tax for the period was ₹905.66 lakhs, while consolidated net profit after tax was ₹891.85 lakhs. The company's earnings per share (basic and diluted) for the quarter stood at ₹1.81 on a standalone basis and ₹1.78 on a consolidated basis.
The company will also publish these financial results in widely circulated English and Hindi newspapers and is in the process of filing them in XBRL format on the company's website. The financial statements were reviewed by the Audit Committee on August 10, 2026, before being taken on record by the Board.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.